Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

COMPARISON Among Citology, Histology, and FLOW Cytometry IN Evaluating Blast VALUES IN Myelodysplatic Syndromes (MDS). Survey FROM the Italian “PIEMONTE MDS REGISTRY”

Blood (2010) 116 (21): 4028.

https://doi.org/10.1182/blood.V116.21.4028.4028

Published: 2010

Journal Articles

A New Acute Monoblastic Leukemia Cell Line Expressing Vascular Endotelial Growth Factor (VEGF) -A and -D and VEGF Receptor-3 (Flt-4).

Dario Ferrero, MD, Graziella Bellone, Ph D, Valentina Giai, M D, Anna Carbone, Ph D, Patrizia Scaravaglio, Ph D, Chiara Dellacasa, M D, Milena Gilestro, Ph D, Mario Boccadoro, MD

Blood (2006) 108 (11): 4496.

https://doi.org/10.1182/blood.V108.11.4496.4496

Published: 2006

Journal Articles

A Ph-Negative Myeloproliferative Disorder with JAK2 Mutation Disclosed by Imatinib Therapy in Two Patients with Ph+ CML.

Emilia Giugliano, BD, Dario Ferrero, MD, Carmen Fava, MD, Chiara Dellacasa, MD, Giovanna Mattioli, MD, Patrizia Scaravaglio, BD, Enrico Gottardi, Stefano Ulisciani, MD, Filomena Daraio, BD, Giuseppe Saglio, MD, Giovanna Rege-Cambrin, MD

Blood (2006) 108 (11): 4910.

https://doi.org/10.1182/blood.V108.11.4910.4910

Published: 2006

Journal Articles

Ph’-Positive (Ph’+) Chronic Myeloid Leukemia (CML) Presenting as Ph’+ T-Lymphoblastic Lymphoma (LL) Resistant to High-Dose Chemotherapy and Gleevec.

Lorenzo Falchi, Giorgia Desantis, Fabrizio Liberati, Roberta Pace, Maria G. Morandi, Patrizia Scaravaglio, Giuseppe Saglio, Anna M. Liberati

Blood (2005) 106 (11): 4869.

https://doi.org/10.1182/blood.V106.11.4869.4869

Published: 2005

Journal Articles

Lack of SH3 domain does not imply a more severe clinical course in Ph + chronic myeloid leukemia patients

Mario Tiribelli, Anna Tonso, Dario Ferrero, Adele Parziale, Giovanna Rege Cambrin, Patrizia Scaravaglio, Daniela Cilloni, Enrico Gottardi, Giuseppe Saglio

Blood (2000) 95 (12): 4019–4020.

https://doi.org/10.1182/blood.V95.12.4019

Published: 2000

NARROW

COMPARISON Among Citology, Histology, and FLOW Cytometry IN Evaluating Blast VALUES IN Myelodysplatic Syndromes (MDS). Survey FROM the Italian “PIEMONTE MDS REGISTRY”

A New Acute Monoblastic Leukemia Cell Line Expressing Vascular Endotelial Growth Factor (VEGF) -A and -D and VEGF Receptor-3 (Flt-4).

A Ph-Negative Myeloproliferative Disorder with JAK2 Mutation Disclosed by Imatinib Therapy in Two Patients with Ph+ CML.

Ph’-Positive (Ph’+) Chronic Myeloid Leukemia (CML) Presenting as Ph’+ T-Lymphoblastic Lymphoma (LL) Resistant to High-Dose Chemotherapy and Gleevec.

Lack of SH3 domain does not imply a more severe clinical course in Ph + chronic myeloid leukemia patients

Email alerts

ASH Publications

American Society of Hematology

COMPARISON Among Citology, Histology, and FLOW Cytometry IN Evaluating Blast VALUES IN Myelodysplatic Syndromes (MDS). Survey FROM the Italian “PIEMONTE MDS REGISTRY”

A New Acute Monoblastic Leukemia Cell Line Expressing Vascular Endotelial Growth Factor (VEGF) -A and -D and VEGF Receptor-3 (Flt-4).

A Ph-Negative Myeloproliferative Disorder with JAK2 Mutation Disclosed by Imatinib Therapy in Two Patients with Ph+ CML.

Ph’-Positive (Ph’+) Chronic Myeloid Leukemia (CML) Presenting as Ph’+ T-Lymphoblastic Lymphoma (LL) Resistant to High-Dose Chemotherapy and Gleevec.

Lack of SH3 domain does not imply a more severe clinical course in Ph + chronic myeloid leukemia patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only